September 25, 2018

FDA: Getinge recalls Maquet/Getinge Cardiosave Intra-Aortic Balloon Pump

By: Judy Mathias
Share

Editor’s Note

The Food and Drug Administration (FDA) on September 30 posted an announcement by Getinge that it is voluntarily initiating a worldwide recall involving a field correction of some 5,223 Maquet/Getinge Cardiosave Intra-Aortic Balloon Pumps (IABP) sold by Datascope Corp.

The recall is because of the potential for interruption and/or inability to start therapy to the patient when using certain intra-aortic balloons before or during use with the Cardiosave IABP at altitudes above 3,200 feet. This could lead to patient hemodynamic instability.

Maquet/Getinge is developing a software correction to address the altitude issue. Installation of the updated software is anticipated to begin February 2019.

Read More >>

Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat